Genesis Research And Development Corporation Limited

 
 

News

MorphoSys Enters Therapeutic Research Collaboration on Novel Target Molecule with Genesis Research

🕔10/8/2007 8:45:15 PM 4527

MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) today announced the signing of a research collaboration with New Zealand-based Genesis Research and Development Corporation Ltd. (New Zealand Stock Exchange: GEN).

Read Full Article▸
###

1,753 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 30) (Since Published: 1753) 

Company Data

    Principal Sector
  • Health & Pharm 
    • Principal Industry
  • Biotechnology 
    • Listed
  • 2000/09/22